Levofloxacin beats rivals in infection control

Article

Topical levofloxacin penetrates better than ofloxcin or ciprofloxacin into the aqueous of eyes with functioning filtering blebs.

Topical levofloxacin penetrates better than ofloxcin or ciprofloxacin into the aqueous of eyes with functioning filtering blebs, concludes a study published in the March issue of the British Journal of Ophthalmology.

Louis Cantor and colleagues from the Indiana University School of Medicine, Indianapolis, USA conducted an investigator-masked study to compare the penetration of levofloxacin, ofloxacin and ciprofloxacin.

A total of 48 patients with functioning filtering blebs requiring cataract surgery were randomized into six groups of eight patients. Groups one, two and three received topical ofloxacin 0.3%, ciprofloxacin 0.3% and levofloxacin, respectively. Groups four, five and six received the same treatment with the corresponding oral dose of ofloxacin 400 mg, ciprofloxacin 400 mg and levofloxacin 250 mg. Aqueous antibiotic levels were determined by mass spectrometry of aqueous samples from each subject.

The mean aqueous level for topical levofloxacin was significantly higher than those achieved by topical ofloxacin or ciprofloxacin (p=0.02 and 0.01, respectively). Meanwhile, the combination of topical oral levofloxacin was significantly higher than topical levofloxacin alone (p=0.05).

The results of this study suggest that the combination of oral and topical levofloxacin may be preferable in the treatment of bleb-associated infections.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.